161 related articles for article (PubMed ID: 29127397)
1. sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
Zhang CL; Xu YJ; Yang HX; Xu YQ; Shang DS; Wu T; Zhang YP; Li X
Sci Rep; 2017 Nov; 7(1):15322. PubMed ID: 29127397
[TBL] [Abstract][Full Text] [Related]
2. Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.
Tian S; Tian J; Chen X; Li L; Liu Y; Wang Y; Sun Y; Zhang C; Lou G
Cell Physiol Biochem; 2017; 44(4):1325-1336. PubMed ID: 29183027
[TBL] [Abstract][Full Text] [Related]
3. Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Chang H; Gao Q; Ding W; Qing X
PLoS One; 2018; 13(3):e0194245. PubMed ID: 29570744
[TBL] [Abstract][Full Text] [Related]
4. Integrating gene and lncRNA expression to infer subpathway activity for tumor analyses.
Zhang C; Xu Y; Yang H; Xu Y; Dong Q; Liu S; Wu T; Zhang Y
Oncotarget; 2017 Dec; 8(67):111433-111443. PubMed ID: 29340065
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of mRNA-level and miRNA-level subpathway activities for identifying robust ovarian cancer prognostic signatures.
Tian S; Mi W; Zhang M; Xing L; Zhang C
J Cell Mol Med; 2020 Feb; 24(4):2582-2592. PubMed ID: 31957240
[TBL] [Abstract][Full Text] [Related]
6. PROONCOGENIC EFFECTS OF INHIBITING THE microRNA miR-106A IN SKIN MELANOMA CELLS IN VITRO.
Palkina NV; Komina AV; Aksenenko MB; Ruksha TG
Tsitologiia; 2016; 58(9):679-87. PubMed ID: 30198679
[TBL] [Abstract][Full Text] [Related]
7. Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.
Feng L; Xu Y; Zhang Y; Sun Z; Han J; Zhang C; Yang H; Shang D; Su F; Shi X; Li S; Li C; Li X
Oncotarget; 2015 Nov; 6(36):39151-64. PubMed ID: 26472186
[TBL] [Abstract][Full Text] [Related]
8. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
Jayawardana K; Schramm SJ; Tembe V; Mueller S; Thompson JF; Scolyer RA; Mann GJ; Yang J
J Invest Dermatol; 2016 Jan; 136(1):245-254. PubMed ID: 26763444
[TBL] [Abstract][Full Text] [Related]
9. Analysis of melanoma-related microRNAs expression during the spontaneous regression of cutaneous melanomas in MeLiM pigs.
Baco M; Chu CY; Bouet S; Rogel-Gaillard C; Bourneuf E; Le Provost F; Chu CY; Vincent-Naulleau S
Pigment Cell Melanoma Res; 2014 Jul; 27(4):668-70. PubMed ID: 24661544
[No Abstract] [Full Text] [Related]
10. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
[TBL] [Abstract][Full Text] [Related]
11. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
13. Topologically inferring active miRNA-mediated subpathways toward precise cancer classification by directed random walk.
Ning Z; Feng C; Song C; Liu W; Shang D; Li M; Wang Q; Zhao J; Liu Y; Chen J; Yu X; Zhang J; Li C
Mol Oncol; 2019 Oct; 13(10):2211-2226. PubMed ID: 31408573
[TBL] [Abstract][Full Text] [Related]
14. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in malignant melanoma.
Völler D; Ott C; Bosserhoff A
Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Expression Profile in Conjunctival Melanoma.
Larsen AC; Mikkelsen LH; Borup R; Kiss K; Toft PB; von Buchwald C; Coupland SE; Prause JU; Heegaard S
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4205-12. PubMed ID: 27548891
[TBL] [Abstract][Full Text] [Related]
17. Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer.
Han J; Liu S; Jiang Y; Xu C; Zheng B; Jiang M; Yang H; Su F; Li C; Zhang Y
J Cell Mol Med; 2018 Sep; 22(9):4304-4316. PubMed ID: 29971923
[TBL] [Abstract][Full Text] [Related]
18. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
19. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]